SPD489
Drug timelines are a Plus or Pro feature.
22 regulatory and trial events tracked for SPD489, covering 2011-06-23 to 2021-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]